The quadrivalent HPV vaccine, developed by multinational pharmaceutical company Merck, was approved on Jan 8 for males on the Chinese mainland. The vaccine targets HPV types 6, 11, 16 and 18. The ...

The human papillomavirus (HPV) is the most common sexually transmitted infection, and most people will have exposure at some ...

Cervical cancer is often highly treatable, with a five-year relative survival rate of 91% for localised, early-stage disease.

It is the leading cause of cancer mortality in Kenya, with an estimated 3,200 deaths in 2020. It is also a significant global health concern, affecting millions of women worldwide.

It is the leading cause of cancer mortality in Kenya, with an estimated 3,200 deaths in 2020. It is also a significant global health concern, affecting millions of women worldwide.

Island Health nurses are visiting schools across the region in the coming weeks to offer the human papillomavirus (HPV) ...

HPV can cause a variety of cancers, including cervical. New mortality data for women under 25 point to the success of the HPV vaccine.

The HPV vaccine prevents HPV-related cancers and diseases, yet myths persist. Expert debunks misconceptions, emphasising its safety, early administration, and the importance of vaccination for all ...

Men and women between the ages of nine and 45 can get the vaccine but it is highly recommended to vaccinate children earlier ...

TWO women lose their lives to cervical cancer every day in the UK. Like all types of the disease, the earlier it’s caught, the better. Around 95 per cent of those diagnosed at stage 1 will ...

The medical community has observed an alarming trend in recent decades – a significant surge in throat cancer cases across ...